Sign in

Filings

Finds words inside filing documents. Searching ABVC BIOPHARMA, INC.'s filings · 28 documents indexed.

9 documents · 30 matches

  1. ABVC ABVC BIOPHARMA, INC. 10-K 2026-03-03

    Item 1A. Risk Factors

    material weakness, our disclosure controls and procedures were not effective as of December 31, 2025. Due to such material weakness
    10 matches in this document

  2. ABVC ABVC BIOPHARMA, INC. 10-Q 2026-11-10

    Item 4. Controls and Procedures.

    material weakness, we were unable to maintain effective disclosure controls over financial reporting, which did result in material misstatements in our financial
    3 matches in this document

  3. ABVC ABVC BIOPHARMA, INC. 10-Q 2026-08-12

    Item 4. Controls and Procedures.

    material weakness, we were unable to maintain effective disclosure controls over financial reporting, which did result in material misstatements in our financial
    3 matches in this document

  4. ABVC ABVC BIOPHARMA, INC. 10-Q 2026-05-18

    Item 4. Controls and Procedures.

    material weakness, we were unable to maintain effective disclosure controls over financial reporting, which did result in material misstatements in our financial
    3 matches in this document

  5. ABVC ABVC BIOPHARMA, INC. 10-Q/A 2026-03-03

    Item 4. Controls and Procedures.

    material weakness, we were unable to maintain effective disclosure controls over financial reporting, which did result in material misstatements in our financial
    3 matches in this document

  6. ABVC ABVC BIOPHARMA, INC. 10-Q 2025-11-03

    Item 4. Controls and Procedures.

    material weakness, we were unable to maintain effective disclosure controls over financial reporting, which did result in material misstatements in our financial
    3 matches in this document

  7. ABVC ABVC BIOPHARMA, INC. 10-Q 2025-08-13

    Item 4. Controls and Procedures.

    material weakness, we were unable to maintain effective disclosure controls over financial reporting, which did result in material misstatements in our financial
    3 matches in this document

  8. ABVC ABVC BIOPHARMA, INC. 8-K 2026-07-02

    Item 4.01. Changes in Registrant’s Certifying Accountant.

    Regulation S-K, except for the previously disclosed identification of material weaknesses in the Company’s internal control over financial reporting.
    1 match in this document

  9. ABVC ABVC BIOPHARMA, INC. 8-K 2026-03-03

    Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

    material weakness in its internal controls over financial reporting and shall include such determination in its Annual Report on Form
    1 match in this document

Page 1 of 1 · 9 documents